<DOC>
	<DOCNO>NCT00131378</DOCNO>
	<brief_summary>This study compare growth hormone level cardiovascular risk marker normal weight overweight woman men . In woman men increase abdominal weight , growth hormone ( GH ) versus placebo administer effect cardiovascular risk , insulin resistance body composition measure .</brief_summary>
	<brief_title>Growth Hormone , Cardiovascular Risk , Visceral Adiposity</brief_title>
	<detailed_description>The purpose study measure growth hormone level woman men normal weight , overweight , obese . Growth hormone level correlate body weight , body composition , marker cardiovascular risk . In overweight obese woman men increase visceral adiposity average IGF-1 level , growth hormone versus placebo give 6 month . Effects growth hormone treatment weight , body composition , insulin resistance , lipid , cardiovascular risk marker assess . Study subject follow additional six month endpoint .</detailed_description>
	<mesh_term>Hormones</mesh_term>
	<criteria>For growth hormone measurement part ( men woman ) : 1 . For visceral adiposity arm : waist circumference great equal 88 cm woman 102 cm men , BMI great equal 25 kg/m2 2 . For lean control : BMI 18.5 24.9 kg/m2 For growth hormone treatment part ( men woman ) : 1 . Visceral adiposity ( waist circumference great equal 88 cm woman 102 men , BMI great equal 25 kg/m2 ) 2 . IGFI within low 2 quartile age gender 3 . Willingness maintain current activity level diet Diabetes mellitus ( fast plasma glucose great 126 mg/dL 2hour postoral glucose tolerance test [ OGTT ] plasma glucose great 200 ) Taking follow medication last 3 month : weight loss lipidlowering agent , medication treat diabetes mellitus `` prediabetes '' , oral contraceptive estrogencontaining medication , medication know significantly affect weight Smoking Hematocrit low limit normal Amenorrhea 3 month ( woman ) Pregnant breastfeed ( woman ) Polycystic ovary syndrome ( woman ) Weight exceed 280 pound SGPT great 2 time upper limit normal History malignancy , except fully resolve basal cell carcinoma skin ( Specific Aim 2 ) Radiation exposure great 1000 mrem last 12 month Previous diagnosis cardiovascular disease History pituitary hypothalamic disease , brain radiation , childhood growth hormone deficiency History carpal tunnel syndrome surgically treat</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Visceral obesity</keyword>
	<keyword>Growth hormone</keyword>
	<keyword>Cardiovascular risk</keyword>
	<keyword>Insulin resistance</keyword>
</DOC>